Cover Image
市場調查報告書

高活性原料藥 (HPAPI) 市場:全球產業分析、規模、佔有率、成長率、趨勢、預測 2015-2023年

High Potency Active Pharmaceutical Ingredient (HPAPI) Market (Oncology, Anti-Diabetic, Cardiovascular, Central Nervous System, Musculoskeletal and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

出版商 Transparency Market Research 商品編碼 253515
出版日期 內容資訊 英文 85 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
高活性原料藥 (HPAPI) 市場:全球產業分析、規模、佔有率、成長率、趨勢、預測 2015-2023年 High Potency Active Pharmaceutical Ingredient (HPAPI) Market (Oncology, Anti-Diabetic, Cardiovascular, Central Nervous System, Musculoskeletal and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023
出版日期: 2015年12月24日 內容資訊: 英文 85 Pages
簡介

本報告以全球高活性原料藥 (HPAPI) 市場為主題、考慮各種宏觀經濟要素、微觀經濟要素並提供全面分析、HPAPI的種類、製造商種類、藥物的種類、治療領域,及各地區的市場分析與預測,及主要企業簡介等彙整,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 全球HPAPI市場概要

  • 市場定義、概要
  • 法規形勢
  • 主要HPAPI CMO的HPAPI製造能力
  • 市場動態
  • 波特的五力分析
  • 活動的影響分析
  • 價值鏈分析
  • 市場魅力度分析
  • 市場佔有率分析

第4章 全球HPAPI市場:HPAPI的各類型

  • 合成HPAPI市場收益
  • 生技藥品HPAPI市場收益

第5章 全球HPAPI市場:各廠商類型

  • 專屬式或公司內部HPAPI市場收益
  • 契約或第三方HPAPI市場收益

第6章 全球HPAPI市場:各藥物類型

  • 首發HPAPI市場收益
  • 後出發HPAPI市場收益

第7章 全球HPAPI市場:各治療領域

  • 癌症治療藥市場收益
  • 抗糖尿病藥物市場收益
  • 心血管治療藥市場收益
  • 中樞神經系支配療藥市場收益
  • 肌肉骨骼系支配療藥市場收益
  • 其他治療藥市場收益

第8章 全球HPAPI市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東 & 非洲

第9章 建議

第10章 企業簡介

  • Alkermes plc
  • Cambrex Corporation
  • Dr. Reddy's Laboratories
  • Lonza Group
  • Novasep
  • Sandoz International GmbH
  • Pfizer, Inc.
  • Sigma-Aldrich Co. LLC.
  • WuXi AppTec

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Global high potency active pharmaceutical ingredient (HPAPI) market report provides comprehensive analysis considering various macro as well as micro economic factors. The report studies the HPAPI market from five perspectives: type of HPAPI, type of manufacturer, type of drug, therapeutic area, and geography.

The global high potency active pharmaceutical ingredient market report provides insights on contract versus captive HPAPI, synthetic versus biological HPAPI, and branded versus generic HPAPI. The global high potency active pharmaceutical ingredient market is also segmented into major therapeutic areas which include oncology, anti-diabetic, cardiovascular, central nervous system, musculoskeletal and others. From geography perspective, the market is studied for five main geographies: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America HPAPI market is sub-segmented for the U.S., Canada, while Europe HPAPI market is further segmented for Germany, U.K., and Rest of Europe. Asia Pacific HPAPI market is segmented for Japan, China and Rest of Asia Pacific. Latin America market is segmented for Brazil and Rest of Latin America. Middle East and Africa HPAPI market segmented for GCC Countries and Rest of Middle East and Africa.

Market size for each of the aforementioned segments and sub-segments is provided in US$ Mn considering 2013 and 2014 as base years and forecast from 2015 to 2023. The forecast model considers various factors such as drug patent expiry, therapeutic indication, prevalence, generic competition, anticipated drug approvals, impact of regulatory policies, industry pricing strategies and others. The research methodology is a blend of primary as well as secondary market research, where market estimates based on desk research are further refined considering inputs from expert interviews.

The global high potency active pharmaceutical ingredient market report also provides qualitative information on HPAPI manufacturing capabilities of major players in the market. The report also includes details on current regulatory policies. Major factors driving and restraining the global HPAPI market are also discussed in the report, while lucrative opportunities from future perspective are also mentioned. Furthermore, the global high potency active pharmaceutical ingredient market report also provides event impact analysis, which maps key events impacting market growth including facility expansion, mergers and acquisitions, changes in regulatory policies, drug approval, drug patent expiry and generic or biosimilars drug approval. Value chain analysis is also provided for comprehensive analysis. Porter's five forces analysis and market share analysis of high potency active pharmaceutical ingredient market provides detailed information on current competitive landscape of the global HPAPI market. Furthermore, market attractiveness analysis provides information on most attractive geographies for HPAPI manufacturing.

Finally, the report profiles major players in the global HPAPI market which include Alkermes plc, Cambrex Corporation, Dr. Reddy's Laboratories, Lonza Group, Novasep, Sandoz International GmbH, Pfizer, Inc., Sigma-Aldrich Co. LLC., WuXi AppTec. Each of the companies are profiled for parameters including: company overview, financial overview, product portfolio, business strategies and recent developments The report represents HPAPI market estimation and forecast in the form of 26 charts and figures, and 4 tables and comprises 85 slides.

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
  • 1.4 Assumptions

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global HPAPI Market
  • 2.2 Comparative Analysis: HPAPI Market, by Geography, 2014 & 2023
  • 2.3 Waterfall Chart: Global HPAPI Market, by Product, 2014 (US$ Mn)

Chapter 3 Global HPAPI Market Overview

  • 3.1 Market Definition and Overview
  • 3.2 Regulatory Landscape
  • 3.3 HPAPI Manufacturing Capabilities of Major HPAPI CMOs
  • 3.2 Market Dynamics
    • 3.2.1 Drivers
    • 3.2.2 Restraints
    • 3.2.3 Opportunities
  • 3.3 Porter's Five Forces Analysis: Global HPAPI Market
  • 3.5 Event Impact analysis
  • 3.6 Value Chain Analysis
  • 3.7 Market Attractiveness Analysis
  • 3.8 Market Share Analysis

Chapter 4 Global HPAPI Market, by Type of HPAPI, 2013 - 2023 (US$ Mn)

  • 4.1 Synthetic HPAPI Market Revenue, 2013 - 2023 (US$ Mn)
  • 4.2 Biological HPAPI Market Revenue, 2013 - 2023 (US$ Mn)

Chapter 5 Global HPAPI Market, by Type of Manufacturer, 2013 - 2023 (US$ Mn)

  • 5.1 Captive or In-house HPAPI Market Revenue, 2013 - 2023 (US$ Mn)
  • 5.2 Contract or Third Party HPAPI Market Revenue, 2013 - 2023 (US$ Mn)

Chapter 6 Global HPAPI Market, by Type of Drug, 2013 - 2023 (US$ Mn)

  • 6.1 Branded HPAPI Market Revenue, 2013 - 2023 (US$ Mn)
  • 6.2 Generic HPAPI Market Revenue, 2013 - 2023 (US$ Mn)

Chapter 7 Global HPAPI Market, by Therapeutic Area, 2013 - 2023 (US$ Mn)

  • 7.1 Oncology Drugs Market Revenue, 2013 - 2023 (US$ Mn)
  • 7.2 Anti-diabetic Drugs Market Revenue, 2013 - 2023 (US$ Mn)
  • 7.3 Cardiovascular Drugs Market Revenue, 2013 - 2023 (US$ Mn)
  • 7.4 Central Nervous System Drugs Market Revenue, 2013 - 2023 (US$ Mn)
  • 7.5 Musculoskeletal Drugs Market Revenue, 2013 - 2023 (US$ Mn)
  • 7.6 Other Drugs Market Revenue, 2013 - 2023 (US$ Mn)

Chapter 8 Global HPAPI Market, by Geography, 2013 - 2023 (US$ Mn)

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 U.S. Market Revenue, 2013 - 2023 (US$ Mn)
    • 8.2.2 Canada Market Revenue, 2013 - 2023 (US$ Mn)
  • 8.3 Europe
    • 8.3.1 U.K. Market Revenue, 2013 - 2023 (US$ Mn)
    • 8.3.2 Germany Market Revenue, 2013 - 2023 (US$ Mn)
    • 8.3.3 Rest of Europe Market Revenue, 2013 - 2023 (US$ Mn)
  • 8.4 Asia Pacific
    • 8.4.1 Japan Market Revenue, 2013 - 2023 (US$ Mn)
    • 8.4.2 China Market Revenue, 2013 - 2023 (US$ Mn)
    • 8.4.3 Rest of Asia Pacific Market Revenue, 2013 - 2023 (US$ Mn)
  • 8.5 Latin America
    • 8.5.1 Brazil Market Revenue, 2013 - 2023 (US$ Mn)
    • 8.5.2 Rest of Latin America Market Revenue, 2013 - 2023 (US$ Mn)
  • 8.6 Middle East & Africa
    • 8.6.1 GCC Countries Market Revenue, 2013 - 2023 (US$ Mn)
    • 8.6.2 Rest of Middle East and Africa Market Revenue, 2013 - 2023 (US$ Mn)

Chapter 9 Recommendations

Chapter 10 Company Profiles

  • 10.1 Alkermes plc
  • 10.2 Cambrex Corporation
  • 10.3 Dr. Reddy's Laboratories
  • 10.4 Lonza Group
  • 10.5 Novasep
  • 10.6 Sandoz International GmbH
  • 10.7 Pfizer, Inc.
  • 10.8 Sigma-Aldrich Co. LLC.
  • 10.9 WuXi AppTec
Back to Top